Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression

NCT01284517 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

356

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Depression

Interventions

DRUG: Lurasidone
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.